Covered recipient · General Payments record
TYLER ELAM
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,182.12
- Reported across 156 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $387.56 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $232.52 | 18 |
| GlaxoSmithKline, LLC. | $72.32 | 4 |
| Gilead Sciences, Inc. | $48.96 | 2 |
| Novo Nordisk AS | $33.76 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.69 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103683815 | CMS |
| ABBVIE INC. | $10.89 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103683817 | CMS |
| ABBVIE INC. | $22.18 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103683819 | CMS |
| ABBVIE INC. | $24.42 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103683821 | CMS |
| ABBVIE INC. | $9.92 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103683823 | CMS |
| ABBVIE INC. | $2.64 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103683825 | CMS |
| ABBVIE INC. | $8.53 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103683827 | CMS |
| ABBVIE INC. | $8.13 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103683829 | CMS |
| ABBVIE INC. | $15.10 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103683831 | CMS |
| ABBVIE INC. | $12.37 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103683833 | CMS |
| ABBVIE INC. | $3.28 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103683835 | CMS |
| ABBVIE INC. | $17.87 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103683837 | CMS |
| ABBVIE INC. | $0.43 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103683839 | CMS |
| ABBVIE INC. | $11.92 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103683841 | CMS |
| ABBVIE INC. | $15.76 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103683843 | CMS |
| ABBVIE INC. | $20.26 | 08/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103683845 | CMS |
| ABBVIE INC. | $26.13 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103683847 | CMS |
| ABBVIE INC. | $13.00 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103683849 | CMS |
| Gilead Sciences, Inc. | $23.28 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133634355 | CMS |
| Gilead Sciences, Inc. | $25.68 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133634357 | CMS |
| GlaxoSmithKline, LLC. | $18.23 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116524548 | CMS |
| GlaxoSmithKline, LLC. | $17.17 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116063089 | CMS |
| GlaxoSmithKline, LLC. | $17.17 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116618397 | CMS |
| GlaxoSmithKline, LLC. | $19.75 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116695723 | CMS |
| Novo Nordisk Inc | $18.45 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097385458 | CMS |
| Novo Nordisk Inc | $15.31 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097253608 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.